Solu-Medrol

Stevens-Johnson Syndrome, Pemphigus, Ophthalmia, Sympathetic + 45 more
Treatment
5 FDA approvals
20 Active Studies for Solu-Medrol

What is Solu-Medrol

Methylprednisolone hemisuccinateThe Generic name of this drug
Treatment SummaryMethylprednisolone is a type of steroid medication that is more powerful than prednisone. It was approved by the FDA in 1957 and is currently being studied as a potential treatment for COVID-19-associated pneumonia in those with weakened immune systems. Clinical trials are underway to determine the efficacy of methylprednisolone in treating this virus.
Solu-medrolis the brand name
image of different drug pills on a surface
Solu-Medrol Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Solu-medrol
Methylprednisolone hemisuccinate
1959
89

Approved as Treatment by the FDA

Methylprednisolone hemisuccinate, also known as Solu-medrol, is approved by the FDA for 5 uses including Tuberculosis, Pulmonary and Tuberculosis, Pulmonary .
Tuberculosis, Pulmonary
Used to treat disseminated Pulmonary Tuberculosis (TB) in combination with null
Tuberculosis, Pulmonary
Used to treat fulminating Pulmonary Tuberculosis in combination with null
Tuberculous Meningitis
Used to treat Tuberculous Meningitis in combination with null
Tuberculosis, Meningeal
Used to treat Tuberculous Meningitis in combination with null
Subarachnoid Block
Used to treat Subarachnoid Block in combination with null

Effectiveness

How Solu-Medrol Affects PatientsCorticosteroids help reduce inflammation by binding to the glucocorticoid receptor. They are often given in doses that are much higher than what the body would normally produce. Taking corticosteroids can lead to a decreased ability to fight off infections and other issues, so it's important to be aware of these risks before starting treatment.
How Solu-Medrol works in the bodyCorticosteroids help reduce swelling and inflammation in the body. They do this by changing gene expression, preventing white blood cells from moving to sites of inflammation, and reducing the production of substances that cause inflammation. Lower doses are anti-inflammatory, while higher doses are immunosuppressive. Long-term, high doses of corticosteroids can raise sodium levels and lower potassium levels.

When to interrupt dosage

The recommended dosage of Solu-Medrol is contingent upon the identified condition, including Inflammation, Necrobiosis lipoidica diabeticorum and Diuresis. The dosage quantity oscillates, commensurate with the administration technique outlined in the table beneath.
Condition
Dosage
Administration
Mycosis Fungoides
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Polymyositis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Addison Disease
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Eosinophilic Pneumonia
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Dermatitis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Multiple Sclerosis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Trichinosis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Thrombocytopenia
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Sarcoidosis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Acute Coryza
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Anemia, Hemolytic
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Craniotomy
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Thyroiditis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
exfoliative erythroderma
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
induction of Diuresis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Diuresis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Arthritis, Gouty
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Giant Cell Arteritis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Brain
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Dermatomyositis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Warnings

Solu-Medrol Contraindications
Condition
Risk Level
Notes
intrathecal administration
Do Not Combine
Mycoses
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Methylprednisolone Hemisuccinate may interact with Pulse Frequency
There are 20 known major drug interactions with Solu-Medrol.
Common Solu-Medrol Drug Interactions
Drug Name
Risk Level
Description
Aldesleukin
Major
The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate.
Corticorelin ovine triflutate
Major
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone hemisuccinate.
Macimorelin
Major
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Methylprednisolone hemisuccinate.
1,10-Phenanthroline
Minor
The therapeutic efficacy of 1,10-Phenanthroline can be decreased when used in combination with Methylprednisolone hemisuccinate.
Aceclofenac
Minor
The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone hemisuccinate is combined with Aceclofenac.
Solu-Medrol Toxicity & Overdose RiskThe toxic dose of glucocorticoids in rats is more than 4g/kg. In mice, the toxic dose is 2292mg/kg, and in rats it is 100mg/kg. If a person takes a large amount of glucocorticoids chronically, they may experience cataracts, glaucoma, high blood pressure, water retention, high cholesterol, ulcers, pancreatitis, muscle weakness, mood changes, psychosis, thinning skin, allergies, acne, increased body hair, lowered immunity, moon face, high blood sugar, low calcium or phosphate levels, acidosis, stunted growth,
image of a doctor in a lab doing drug, clinical research

Solu-Medrol Novel Uses: Which Conditions Have a Clinical Trial Featuring Solu-Medrol?

594 active clinical trials are currently examining the potential of Solu-Medrol to mitigate Asthma, Atopic Dermatitis and Ulcerative Colitis.
Condition
Clinical Trials
Trial Phases
Metastatic Brain Tumors
60 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 3, Phase 4
Psoriatic Arthritis
25 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 4, Phase 2
Ulcerative Colitis
13 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Phase 1
Thrombocytopenia
0 Actively Recruiting
Palliative Treatment
1 Actively Recruiting
Phase 3
Berylliosis
0 Actively Recruiting
Adrenal Insufficiency
0 Actively Recruiting
Diuresis
0 Actively Recruiting
Anemia, Hemolytic
0 Actively Recruiting
Brain
0 Actively Recruiting
Brain
7 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1
Lupus Erythematosus
3 Actively Recruiting
Phase 4, Phase 1
Crohn Disease
0 Actively Recruiting
Subarachnoid Block
0 Actively Recruiting
Stevens-Johnson Syndrome
2 Actively Recruiting
Phase 3, Phase 1
exfoliative erythroderma
0 Actively Recruiting
Arthritis, Gouty
0 Actively Recruiting
Addison Disease
0 Actively Recruiting
Multiple Sclerosis
0 Actively Recruiting
Craniotomy
0 Actively Recruiting

Solu-Medrol Reviews: What are patients saying about Solu-Medrol?

5Patient Review
8/21/2013
Solu-Medrol for Rheumatoid Arthritis
Solumedral has been an absolute wonder drug for me. I was experiencing debilitating side effects from Taxol and Carbo Platin, but this medication (along with a few others) have almost completely alleviated them.
5Patient Review
4/18/2013
Solu-Medrol for Allergic Reaction caused by a Drug
I didn't notice any difference.
4.7Patient Review
1/17/2014
Solu-Medrol for Multiple Sclerosis
I had an allergic reaction and used my EpiPen. I went to the ER and they gave me IV Benadryl and Solu-Medrol. The Solu-Medrol made me so anxious that I had tachycardia. I felt awful. I was stuck in the ER for 5 hours until the tachycardia subsided.
4.7Patient Review
4/2/2017
Solu-Medrol for Eye Disorder
I experienced some serious side effects while using this medication, but it was effective in reducing the inflammation in my eyes. I no longer have double vision and have recovered most of the mobility in my eyes.
4.3Patient Review
8/20/2014
Solu-Medrol for Multiple Sclerosis
It's easy for me to administer this treatment; the home health nurse starts it when I receive the first dose. I have a port because I have another blood condition which requires monthly IV infusions. This isn't my first time dealing with this, so I'm familiar with the process and not too worried. My blood pressure is going up, but that might just be because I'm in severe pain right now.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about solu-medrol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does Solu-Medrol take to work?

"The medicine will have an effect 6 to 48 hours after it is injected into a muscle. Its effect will be noticeable sooner if it is injected into a vein."

Answered by AI

Is Solu-Medrol the same as prednisone?

"A lower dosage of methylprednisolone is used because it is slightly stronger than prednisone."

Answered by AI

What is Solu-Medrol used for?

"This medication can help to relieve symptoms associated with different medical conditions, including arthritis, blood disorders, severe allergies, certain types of cancer, eye conditions, and skin, kidney, intestinal, and lung diseases. It can also be used to help improve the function of the immune system."

Answered by AI

Is Solu-Medrol a steroid?

"The drug also acts as an immunosuppressant, and is used in the preventative treatment of organ transplantation.

Solu-Medrol is a man-made steroid. It is used to treat severe allergies, skin diseases, hormone disorders, gut diseases, and joint diseases. It also suppresses the immune system, and is used to prevent organ transplant rejection."

Answered by AI

Clinical Trials for Solu-Medrol

Have you considered Solu-Medrol clinical trials? We made a collection of clinical trials featuring Solu-Medrol, we think they might fit your search criteria.
Have you considered Solu-Medrol clinical trials? We made a collection of clinical trials featuring Solu-Medrol, we think they might fit your search criteria.
Have you considered Solu-Medrol clinical trials? We made a collection of clinical trials featuring Solu-Medrol, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top